Recent Discoveries and Developments of Androgen Receptor-Based Therapy for Prostate Cancer
January 2015
in “
MedChemComm
”
androgen receptor AR antagonists Enzalutamide MDV3100 castration-resistant prostate cancer CRPC nonsteroidal antiandrogens Luteinizing hormone-releasing hormone LH-RH agonists LH-RH antagonists androgen deprivation therapy ADT AR splice variants AR-V7 selective androgen receptor modulators SARMs natural antiandrogens LH-RH
Studysummary New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on pubs.rsc.org →